Analysts: 2013 could be big for CROs

Last year, growth in the CRO world was mostly flat, but, looking at projections from some of the industry's largest firms, analysts at Sterne, Agee & Leach say contract researchers could be poised for between 5% and 10% year-over-year growth in 2013. Report (sub. req.)

Suggested Articles

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.

Aetion has raised $50 million so far, and it plans to enhance its platform to support more complex therapeutic areas and expand its team.

Charles River partners with PathoQuest to offer clients NGS solutions for biologics viral contamination testing and cell-line genetic characterization.